Style | Citing Format |
---|---|
MLA | Ap Javaherdehi Atefe PANAHIPOOR, et al.. "Identification of Effective Inhibitors Against Epsilon Toxin (Etx) of Clostridium Perfringens: Virtual Screening and Molecular Dynamics Simulation." Toxicon, vol. 264, no. , 2025, pp. -. |
APA | Ap Javaherdehi Atefe PANAHIPOOR, Zs Hashemi Zahra SADAT, S Khaleghi SEPIDEH, G Bayazian GHOLAMREZA (2025). Identification of Effective Inhibitors Against Epsilon Toxin (Etx) of Clostridium Perfringens: Virtual Screening and Molecular Dynamics Simulation. Toxicon, 264(), -. |
Chicago | Ap Javaherdehi Atefe PANAHIPOOR, Zs Hashemi Zahra SADAT, S Khaleghi SEPIDEH, G Bayazian GHOLAMREZA. "Identification of Effective Inhibitors Against Epsilon Toxin (Etx) of Clostridium Perfringens: Virtual Screening and Molecular Dynamics Simulation." Toxicon 264, no. (2025): -. |
Harvard | Ap Javaherdehi Atefe PANAHIPOOR et al. (2025) 'Identification of Effective Inhibitors Against Epsilon Toxin (Etx) of Clostridium Perfringens: Virtual Screening and Molecular Dynamics Simulation', Toxicon, 264(), pp. -. |
Vancouver | Ap Javaherdehi Atefe PANAHIPOOR, Zs Hashemi Zahra SADAT, S Khaleghi SEPIDEH, G Bayazian GHOLAMREZA. Identification of Effective Inhibitors Against Epsilon Toxin (Etx) of Clostridium Perfringens: Virtual Screening and Molecular Dynamics Simulation. Toxicon. 2025;264():-. |
BibTex | @article{ author = {Ap Javaherdehi Atefe PANAHIPOOR and Zs Hashemi Zahra SADAT and S Khaleghi SEPIDEH and G Bayazian GHOLAMREZA}, title = {Identification of Effective Inhibitors Against Epsilon Toxin (Etx) of Clostridium Perfringens: Virtual Screening and Molecular Dynamics Simulation}, journal = {Toxicon}, volume = {264}, number = {}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Ap Javaherdehi Atefe PANAHIPOOR AU - Zs Hashemi Zahra SADAT AU - S Khaleghi SEPIDEH AU - G Bayazian GHOLAMREZA TI - Identification of Effective Inhibitors Against Epsilon Toxin (Etx) of Clostridium Perfringens: Virtual Screening and Molecular Dynamics Simulation JO - Toxicon VL - 264 IS - SP - EP - PY - 2025 ER - |